Inner Mongolia Furui Med Sci Market Cap ($1.49 Billion)
Market Cap & Net Worth: Inner Mongolia Furui Med Sci (300049)
Inner Mongolia Furui Med Sci market cap. Inner Mongolia Furui Med Sci (SHE:300049) has a market capitalization of $1.49 Billion (CN¥10.16 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #6989 globally and #1391 in its home market, demonstrating a -0.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inner Mongolia Furui Med Sci's stock price CN¥38.50 by its total outstanding shares 263991100 (263.99 Million). Also see Inner Mongolia Furui Med Sci operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Inner Mongolia Furui Med Sci Market Cap History (2015–2026)
Inner Mongolia Furui Med Sci market cap history from 2015 to 2026. Data shows growth from $1.17 Billion to $1.49 Billion (2.51% CAGR). Check Inner Mongolia Furui Med Sci stock price for real-time trading data and today's change.
Inner Mongolia Furui Med Sci Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inner Mongolia Furui Med Sci's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300049 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.71x
Inner Mongolia Furui Med Sci's market cap is 1.71 times its annual revenue
Latest Price to Earnings (P/E) Ratio
17.65x
Inner Mongolia Furui Med Sci's market cap is 17.65 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $792.13 Million | $826.99 Million | $121.05 Million | 0.96x | 6.54x |
| 2017 | $507.82 Million | $823.33 Million | $61.11 Million | 0.62x | 8.31x |
| 2018 | $388.62 Million | $867.03 Million | $35.42 Million | 0.45x | 10.97x |
| 2019 | $291.28 Million | $831.74 Million | $43.39 Million | 0.35x | 6.71x |
| 2020 | $312.74 Million | $807.53 Million | $61.91 Million | 0.39x | 5.05x |
| 2021 | $563.39 Million | $898.48 Million | $95.47 Million | 0.63x | 5.90x |
| 2022 | $936.30 Million | $1.01 Billion | $97.89 Million | 0.93x | 9.56x |
| 2023 | $1.68 Billion | $1.15 Billion | $101.56 Million | 1.46x | 16.58x |
| 2024 | $1.22 Billion | $1.35 Billion | $113.29 Million | 0.90x | 10.76x |
| 2025 | $2.72 Billion | $1.59 Billion | $154.09 Million | 1.71x | 17.65x |
Competitor Companies of 300049 by Market Capitalization
Companies near Inner Mongolia Furui Med Sci in the global market cap rankings as of November 5, 2026. Also see total assets of Inner Mongolia Furui Med Sci for a full breakdown of the balance sheet.
Key companies related to Inner Mongolia Furui Med Sci by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #368 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #414 globally with a market cap of $68.22 Billion USD ( AU$96.41 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $530.76 |
| #368 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $973.36 |
| #414 | CSL Ltd | AU:CSL | $68.22 Billion | AU$198.72 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $228.44 |
Market Capitalization of Inner Mongolia Furui Med Sci (2015–2026)
Market capitalization of Inner Mongolia Furui Med Sci from 2015 to today. Between 2015 and today, Inner Mongolia Furui Med Sci's market cap moved from $1.17 Billion to $ 1.49 Billion, with a yearly change of 2.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.49 Billion | -45.32% |
| 2025 | CN¥2.72 Billion | +123.24% |
| 2024 | CN¥1.22 Billion | -27.64% |
| 2023 | CN¥1.68 Billion | +79.84% |
| 2022 | CN¥936.30 Million | +66.19% |
| 2021 | CN¥563.39 Million | +80.15% |
| 2020 | CN¥312.74 Million | +7.37% |
| 2019 | CN¥291.28 Million | -25.05% |
| 2018 | CN¥388.62 Million | -23.47% |
| 2017 | CN¥507.82 Million | -35.89% |
| 2016 | CN¥792.13 Million | -32.11% |
| 2015 | CN¥1.17 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Inner Mongolia Furui Med Sci was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.49 Billion USD |
| MoneyControl | $1.49 Billion USD |
| MarketWatch | $1.49 Billion USD |
| marketcap.company | $1.49 Billion USD |
| Reuters | $1.49 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Inner Mongolia Furui Med Sci
Inner Mongolia Furui Medical Science Co., Ltd. engages in the production and sale of pharmaceutical drugs in China and internationally. The company also engages in the research and development and sales of diagnostic equipment and related medical services. It offers FibroScan series of liver fibrosis diagnostic instruments; FibroMeter series of blood test analysis tools for evaluating chronic liv… Read more